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Inhibitory interneurons participate in all neuronal circuits in the mammalian brain, including the circadian clock system, and are
indispensable for their effective function. Although the clock neurons have different molecular and electrical properties, their main
function is the generation of circadian oscillations. Here we review the circadian plasticity of GABAergic interneurons in several
areas of the mammalian brain, suprachiasmatic nucleus, neocortex, hippocampus, olfactory bulb, cerebellum, striatum, and in the
retina.
1. Introduction
Many aspects of mammalian behavior and physiology show
circadian rhythmicity. The circadian rhythms, with a period
about a day (circa, around and dies, day), are generated by
the central clock or pacemaker that in mammals is located
in suprachiasmatic nuclei (SCN) of the hypothalamus. Under
day/night conditions the pacemaker is entrained by light or
other cyclic environmental cues (so-called Zeitgebers) and
produces oscillations with 24 h period. Circadian informa-
tion generated by the pacemaker is delivered to other brain
regions and to peripheral clocks located in various internal
organs. The pacemaker neurons of the SCN exhibit circadian
rhythm in electric activity and expression of clock genes
which together with their proteins constitute the molecular
mechanism of the clock. This mechanism is based on several
transcriptional/translational feedback loops, negative and
positive [1, 2], and was observed not only in SCN, but also in
themajority of mammalian tissues [3]. In mammals themain
negative feedback loop begins when two transcription factors
CLOCK (CLK) and BMAL1 dimerize and bind to E-box
sequences of promoters of their target genes Per1 (Period),
Per2, and Per3 and Cry1 (Cryptochrome) and Cry2, driving
their rhythmic expression. Next, in the cytoplasm PER and
CRY proteins form heterodimers and translocate to the
nucleus where they stop transcription of their own genes by
inhibiting CLK and BMAL1 transcription factors.This loop is
regulated by many posttranscriptional and posttranslational
processes and interacts with other loops and control cyclic
expression of other, so-called clock-controlled genes (ccg).
This mechanism maintains spontaneous oscillations and is
able to synchronize precisely to the changeable environment
and to control cellular processes by cyclic expression of ccg
and other processes [4–6].
Clock neurons in the SCN besides generating circadian
oscillations also show various circadian rhythms in physiol-
ogy andmorphology. Similar cellular circadian rhythms have
also been observed in many interneurons located in various
brain regions.
Interneurons, including those which display circadian
rhythmicity, constitute very diverse groups of cells with
different physiological, molecular, and morphological char-
acteristics. They allow communication between principal
neurons and participate in the formation of all neural
circuits. Most of them have short axons and form local
circuits but this is not a rule. Hippocamposeptal neurons [7]
and interneurons in the medial entorhinal cortex [8, 9]
innervate distant targets and are called long-range interneu-
rons. In addition to the main neurotransmitters: glutamate,
gamma-aminobutyric acid (GABA), or acetylcholine (Ach)
interneurons also release a wide range of neuropeptides such
as vasoactive intestinal polypeptide (VIP), neuropeptide Y
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(NPY), cholecystokinin (CCK), somatostatin (SOM), and
many more [10, 11].
In vertebrates, themajority of interneurons are inhibitory
and they mainly release GABA. However, GABA can also act
as an excitatory neurotransmitter.During brain development,
GABA is the main excitatory neurotransmitter acting by
GABA A receptors and cooperating with glutamate [12–16].
The effect of GABA includes both excitatory and inhibitory
responses which depend on the neuronal network state [17].
Interestingly, GABAergic excitation mediated by GABA
A receptors was also observed in the mature brain: in
hippocampal interneurons and pyramidal cells [18, 19] as well
as in SCN [20, 21].
In the hippocampus, different changes in cell membrane
potential—hyperpolarization or depolarization—during
GABA neurotransmission were due to different amounts of
the released neurotransmitter, which were associated with
diverse ions mediating GABA effect: chloride and bicar-
bonate anions in case of low and high concentration of
GABA, respectively [22, 23]. Moreover, the excitatory
response to GABA in the pyramidal cells was caused by a
transient increase of extracellular K+ driven by the K+-Cl−
cotransporter isoform 2 and was preceded by intracellular
increase of Cl− [18, 19, 24].
GABA can also act as an excitatory neurotransmitter in
the SCN interneurons [20, 21, 25–27]. According to Wagner
et al. [20] GABA increases the firing frequency of neurons
during the day and decreases it at night. In light/dark con-
ditions, the transmission is mediated by GABA A receptors
linked with chloride channels. It has been postulated that
the observed dual effects of GABA result from diurnal
oscillations in intracellular chloride concentration in the
postsynaptic neurons that is high during the day and low at
night. Gribkoff at al. [28] using the similar concentration of
extracellular potassium ions repeated the previous study of
Wagner et al. [20] and observed only the inhibitory effect
of GABA during the subjective day and the subjective night.
Hee et al. [25] have proposed that GABA-evoked excitatory
response is dependent on Na(+)-K(+)-2Cl(−) cotransporter
isoform 1, which is thought to be responsible for the switch
between depolarization and hyperpolarization evoked by
GABA [14]. In contrast to the results of Wagner et al. [20],
they reported the increase of GABA-mediated excitation
during the night that was also observed in other studies
[21, 27]. This discrepancy probably results from different
recording technique (whole patch clamp versus perforated
patch clamp) and it seems that the excitatory action of GABA
in the SCN occurs throughout day and night but increases
during the night.
Some studies showed that the shift from inhibitory to
excitatory effects of GABAergic transmission is characteristic
predominantly for the dorsal part of the SCN, while neurons
in the ventral part show purely inhibitory response [29, 30].
However, other results indicated a possibility of the excitatory
action of GABAergic transmission in both parts of the SCN
[27]. The conflicting results are probably due to different
conditions of the experiments: time of the day, activity state
of neurons, or recording techniques.
In the regions of the brain which exhibit diurnal and cir-
cadian rhythms, that is, in the SCN, retina, cortex, hippocam-
pus, olfactory bulb, cerebellum, and striatum, inhibitory
interneurons occur in different proportions. Even if they are
in the minority, modulation or deficits of their activity can
have dramatic consequence for network function. GABAer-
gic interneurons not only are responsible for themaintenance
of excitatory/inhibitory balance in the local circuits [31–33]
but alsomay generate intrinsic oscillations to synchronize the
activity of other neurons [34–38].
In SCN, GABA seems to synchronize [35, 38] and desyn-
chronize the neuronal networks [39].The final GABA action,
synchronization or desynchronization, seems to depend
on the response to GABAergic transmission, excitatory or
inhibitory, respectively, as well as to the previous excitation
status of the target neurons [29, 40].
The desynchronization of neuronal networks in the SCN
and in the clock-regulated regions outside the SCN, followed
by loss of circadian rhythmicity, is characteristic for age-
related circadian dysfunctions [41–43]. They probably result
from the disruption of VIPergic and GABAergic signaling in
these regions [44–46].
Changes of circadian plasticity, which are correlated with
disturbances in cyclic GABA production/release by interneu-
rons (mainly cortical), are associated with some neurologi-
cal/psychiatric disorders. These disorders display the loss of
circadian rhythms and dysfunction of excitatory/inhibitory
balance affecting cognitive performance [47] and include
Alzheimer’s disease [48, 49], Parkinson’s disease [50], and
schizophrenia [51, 52], as well as autism and epilepsy [53].
Moreover, extrinsic changes in the circadian rhythm such as
jet lag, social jet lag, or rotating shift work seem to be
correlated with civilization diseases like obesity [54], heart
attacks, and diabetes [55].
The investigations of circadian plasticity related to
GABAergic interneurons have been focused on expres-
sion/concentration of GABA and on colocalized neuropep-
tides and GABA receptors, as well as on the number of
GABAergic synapses and electrophysiological changes of
neurons.
2. Suprachiasmatic Nucleus (SCN)
Mammalian SCN located in the anterior part of hypothala-
mus has been shown to play a role of an oscillator responsible
for controlling circadian rhythms in other parts of the brain.
SCN is divided into two different regions: dorsal and ventral,
containing distinct subpopulations of interneurons. Almost
all interneurons in both regions of the SCN are GABAergic
[56–58] and provide transmission using both classes of
GABA receptors, GABA A and GABA B [59, 60]. The SCN
interneurons usually also contain one or more neuropeptides
which are colocalized with GABA [61, 62].The neurons of the
ventral region produce VIP (themost common neuropeptide
in the SCN), peptide histidine isoleucine (PHI), and gastrin-
releasing peptide (GRP) [63]. The dorsal region contains
neurons producing arginine-vasopressin peptide (AVP). Via
the retinohypothalamic tract, the ventral region receives
Neural Plasticity 3
inputs from photosensitive retinal ganglion cells of which
axons make synaptic contacts with both VIP and non-VIP
interneurons. The secondary photic pathway, the geniculo-
hypothalamic tract which begins in thalamic intergeniculate
leaflet (IGL), also leads to the ventral region of SCN. In
addition projections from themidbrain raphe terminate onto
VIP and AVP neurons in both SCN regions, although they
form more synaptic contacts in the ventral region [64–66].
2.1. Electrophysiological Rhythms. The SCN neurons generate
self-sustained rhythmic activity with approximately 24 h
period and their cyclic neuronal firing is driven by rhythmic
gene expression [67–69]. It has also been demonstrated that
various parameters of synaptic transmission as well as sen-
sitivity of synapses to neuropeptides or electrophysiological
stimulation exhibit circadian or diurnal fluctuations.
The diurnal oscillations of the interneuron conductance
were measured in rat SCN slices and the conductance
recorded at the beginning of the subjective day was 40%
higher than at the beginning of the subjective night [70]. Elec-
trophysiological analyses also showed diurnal rhythmicity in
the holding current (required to hold a neuron at the constant
voltage of−60mV)with a peak in themiddle of the subjective
day andminimum in themiddle of the subjective night.These
methods allow the direct monitoring of ionic conductances
and the observed differences provide evidence that at least
two different ion channels (for Na+ and K+)must be engaged
in driving the diurnal rhythm.
In turn changes in the degree of synaptic depression
were measured by paired-pulse depression (PPD) of synaptic
contacts between the SCN interneurons. Short-term synap-
tic plasticity evoked in this way displayed a clear diurnal
rhythmicity [71]. Moreover, there were two types of PPD
classified according to differences in response to the stimulus,
with shorter or longer intervals and preferential time of PPD
occurrence. The type 1 PPD showed stronger inhibition at
short interstimulus intervals and appeared at the beginning
of the day, while the type 2 was characterized by the strongest
inhibition at longer interstimulus intervals and occurred
preferentially in the middle of the day. It seems that these two
PDD types have also different mechanisms: the first involves
depletion of synaptic vesicles and the second one is Ca(2+)-
dependent [71].
GABA participates in the regulation of amplitude [72, 73]
and phase [74–76] of the SCN rhythms and contributes to the
maintenance and coordination of the neuronal rhythmicity
[29, 40, 72, 77]. It seems that VIP can influence changes in the
degree of synchronization between neurons bymodifying the
frequency of GABA release [78]. Recordings of spontaneous
GABAergic inhibitory postsynaptic currents (IPSCs) showed
that GABAergic inhibition was dependent on the SCN region
and time of the day.Thehighest frequency of IPSCswas found
in the dorsal SCN at the end of the day and at the beginning of
the night under light/dark (LD) conditions [79]. The effect of
VIP onGABAergic inhibition,mediated byVPAC2 receptors,
could be observed in the whole SCN and was more profound
during the day when compared to the night. The IPSCs
rhythmicity of GABAergic interneurons also occurred in
mice kept in constant darkness (DD), indicating the circadian
origin of VIP contribution to GABA transmission [78, 79].
2.2. Molecular Rhythms. Circadian rhythmicity of GABA
content andGAD activity were detected in the rat SCN under
LD and DD conditions, suggesting an endogenous nature of
the fluctuations [80]. In LD conditions, GABA concentration
increased at night and peaked in the middle of the night,
while in DD conditions there was a shift of GABA content
pattern and its highest level was observed at the beginning
of the night. In contrast, GAD activity pattern was similar in
both LD and DD. In addition, content/activity of both GABA
and GAD was higher under LD comparing with DD [80],
what suggests an influence of light on their levels. However,
other studies showed daily [81], but not circadian, rhythm of
GAD65 mRNA level in the rat SCN [82] implying that light
is necessary for GAD rhythmicity.
In rat SCN, VIP and VIP receptor VPCA2 mRNA
levels also showed rhythmicity under LD conditions, with
a maximum at night and minimum during the day [83]. A
similar pattern of pre-pro-VIP/PHI mRNA level changes was
reported by Albers et al. [84]. However, VIP protein con-
centration was constant during the day/night cycle, although
constant light decreased the VIP level [85]. In contrast, Francl
et al. [86] observed the maximum of VIP release in the
midday under LD 14:10 in the hamster SCN and no VIP
rhythmicity in DD conditions. This discrepancy of results
concerning VIP release is most likely caused by different
methods, light/dark conditions, and/or animal models used
in the experiments.
The calbindin- (CalB-) expressing neurons of the hamster
SCN exhibited the circadian rhythm of CalB level under both
LD and DD conditions, with significantly higher expression
during the night and the subjective night [87].
2.3. Structural Rhythms. The analysis of synaptic contacts
between CalB-immunoreactive axons and AVP cells in the
hamster SCN showed an increase in the number of synapses
during the nightwhen comparedwith the day.However, there
were no changes in the number of synapses formed by CalB-
expressing interneurons on other neurons in the SCN like
VIP, CCK, and GRP cells under LD and DD conditions [87].
Postsynaptic densities in the rat SCN synapses formed
by optic nerve terminals on interneurons showed changes
dependent on light conditions and associated with changes in
the number of synapses [88]. Further quantitative analysis of
synapses between glutamatergic and nonglutamatergic axons
representing the retinal input and VIP neurons revealed an
increase in the number of both types of synapses during
the day and a decrease at night. In contrast, the density of
synapses onAVPneuronswas stable during the day and night
[89, 90]. Moreover, the area of glial coverage around VIP
dendrites also exhibited circadian rhythmicity. It increased
at night, probably at the expense of axon terminals on soma
and dendrites of VIP neurons, because axon area decreased
at night [89]. The circadian changes of glial coverage of AVP
dendrites showed an opposite pattern. It decreased during
the night and was accompanied by increase in the area of
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AVP perikarya but not by changes in the number of synapses
[89]. Electron microscopic studies have not shown, however,
any differences in the morphology of glutamatergic axon
terminals between the day and night [90].
Results of studies provide a strong evidence thatGABAer-
gic interneurons affected by VIPergic signaling play a signifi-
cant role in the regulation and synchronization of rhythmicity
in the SCN.
3. Retina
Inhibitory interneurons of the mammalian retina include
amacrine cells and several types of horizontal cells [91].
Amacrine neurons may use both inhibitory neurotransmit-
ters, GABA and glycine, while inhibitory horizontal cells
are typically GABAergic [92, 93]. There are also a few
interplexiform cells expressing GABA [94]. Amacrine cells
are medium to large size neurons that terminate on bipolar
cells, ganglion cells, or other amacrine cells using GABA
A and GABA C receptors for transmission [95]. In some
amacrine cells GABA colocalizes with other neurotransmit-
ters, serotonin, acetylcholine [96], and dopamine [97] or
neuropeptides such as substance P [98], parvalbumin (PV),
SOM,VIP, andNPY [99, 100]. Similarly, glycinergic amacrine
cells can also express CCK [99]. Retinal neurons contain
different calcium-binding proteins, distributed according to
cell classes and sometimes species-specific. For instance AII
types of amacrine cells in the cat retina expresses calretinin
(CalR) [101], while in the rat retina it expresses PV [100].
Diurnal changes in GABA concentration and turnover
were shown under LD 14:10 in the hamster retina, with
a clear minimum in the middle of the day. GAD activity
was also lower in the middle of the day. Both rhythms
were maintained under DD, indicating circadian origin of
GABAergic inhibition [102].
PV expression was studied in amacrine cells of the rat
retina under LD conditions. The level of PV exhibited cyclic
changes with a minimum during the second half of the day
and maximum in the middle of the night. This rhythmicity
was retained under DD; however, after three days of DD the
amplitude of PV level was reduced [103]. The expression of
protein kinase C involved in the control of GABA release in
amacrine cells showed the opposite pattern of rhythmicity
with a peak in the middle of the day and trough in the middle
of the night [104].
These observations suggest that the plasticity of retinal
interneurons not only results from the direct influence of light
but also is controlled by the circadian clock.
4. Neocortex
Inhibitory interneurons constitute about 20% of neocortical
neurons and show a wide range of diversity in electri-
cal and molecular properties as well as in morphological
structure. They have aspiny dendrites, receive soma-targeted
excitatory, and inhibitory inputs and form local connections
within cortical columns, although some of them project
laterally between adjacent columns [10, 105–107]. Neocortical
inhibitory interneurons innervate different subdomains of
pyramidal cells as well as other interneurons [10, 108].
Diurnal rhythms of GABA turnover and GABA A recep-
tor activitywere found in thewhole cerebral cortex of hamster
in LD 14:10 with peaks at night [109, 110]. However, there
were no differences in GABA turnover during the day/night
cycle in hamsters kept under the shorter photoperiod of LD
10:14 [109]. No circadian differences in GABA concentration
were detected in visual and sensorimotor regions of the
human brain [111].There were no circadian changes, either, in
intracortical excitability of GABAergic interneurons located
in the human primary motor cortex [112].
The circadian rhythm in the number of synapses localized
on dendritic spines was demonstrated in layer 4 of the mouse
somatosensory cortex (barrel cortex) which receives sensory
input correlated with the circadian rhythm of locomotor
activity of animals [113, 114]. Under LD conditions, the num-
ber of inhibitory synapses increases during active (nocturnal)
phase of the day/night cycle and achieves a distinct peak
in the middle of the night. The increase in the number of
inhibitory synapses was even more pronounced under DD
conditions [114]. These synapses were formed on dendritic
spines which previously, in the light phase of the cycle, had
excitatory synapses, which means that circadian plasticity of
dendritic spines includes transformation of single-synapse
spines into double-synapse spines. Although it is known that
the inhibitory terminals in the neocortex are intercortical
[115] and there are some candidates for input neurons, for
example, double bouquet cells orMartinotti cells [10, 116], the
source of input to inhibitory synapses in the barrel cortex is
unknown.
As it appears from these studies, somatosensory cortex
seems to be the only neocortical region that exhibits circadian
plasticity of inhibitory interneurons. Future studies of other
neocortical areas are clearly required to extend our knowl-
edge concerning the circadian rhythms in the neocortex.
5. Hippocampus
Hippocampal GABAergic interneurons are mainly basket
and chandelier cells [117, 118]. They innervate dendrites
and cell bodies of pyramidal cells and participate in feed-
back or feedforward circuits [119]. Apart from interneurons
cooperating with principal cells, hippocampus contains the
so-called interneuron-selective cells (IS), innervating other
interneurons and divided according to their connectivity and
neurochemical profile into three types [23]. IS-1 interneurons
express CalR and they are preferentially located in CA1
field, where they form clusters of 10–15 cells connected
dendrodendritically to each other. They give inputs to CalR,
CalB, and VIP neurons [23]. IS-2 interneurons express VIP
and terminate onto CalB and other VIP interneurons; more-
over, they also can innervate interneurons directly inhibiting
pyramidal cells [23, 120]. IS-3 interneurons also include VIP
neurons that are connected mainly with CalB and SOM
neurons [23, 120].The interneuron-selective cells are believed
to control disinhibition in hippocampal networks [23].
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Subnetworks of GABAergic interneurons in the hip-
pocampus may influence excitability of glutamatergic pyra-
midal cells [23]; they are also engaged in the generation of
synchronized network oscillation of hippocampal neurons
[121]. Hence, circadian changes observed in CA1 pyramidal
cells are probably involved in interneuron activity. During
long-term potentiation (LTP) evoked on hippocampal slides
of rats and hamsters under LD conditions, the population
spike (PS) amplitudes doubled during the day comparing
with values at night [122, 123]. However, another study of
CA1 region of rat hippocampus showed an opposite effect:
enhancement of PS during the night in comparison with
the day [124]. A similar observation, that is, greater PS-LTP
during the subjective night, was reported in a study of the
mouse hippocampus in which the pattern of rhythmicity was
retained in DD conditions [125]. Diurnal variations in the
decay of LTP, measured as excitatory postsynaptic potentials
(EPSP), were recorded in CA1 region of the hippocampus
in mice [125] but not in rats [124]. It seems that the
above-mentioned inconsistency of PS-LTP and EPSP-LTP
results might have been caused by different protocols of LTP
evocation. The application of GABA A receptor antagonist
(gabazine) enhanced PS-LTP during the day to the level
observed at night.
These results suggest that the main inhibitory transmis-
sion of hippocampal interneurons during LTP is mediated by
GABA A receptors and is controlled by the circadian clock
[124].
6. Olfactory Bulb
Two main subpopulations of GABAergic interneurons in
olfactory bulb include periglomerular and granular cells [126,
127]. Granular cells have no axons and they release GABA
using specific long dendritic spines forming dendrodendritic
reciprocal synapses with mitral cells [126, 128]. Periglomeru-
lar cells terminate onto mitral and tufted cells [126] and
are more effective in inhibition of mitral cells than granular
cells. They are probably responsible for baseline inhibition,
while granular cells are involved in facilitating this inhibition
[129]. A fraction of periglomerular cells coexpress GABA and
dopamine [130].
VIPergic interneurons were observed in the external
plexiform layer, periglomerular layer, and granule cell layer
of mouse olfactory bulb, while expression of VIP receptor
(VPAC2)was detected inmitral and external tufted cells [131].
Intrinsic circadian rhythms of firing rate and clock gene
expression were observed in olfactory bulb in vitro [132]. In
mice, the circadian rhythm of odor perception sensitivity was
detected in the absence of environmental time cues, and it
was depended on clock gene expression [133]. Moreover, the
rhythm persisted when circadian rhythms were not present
in the SCN [134] or when the SCN was ablated [135]. Hence,
olfaction seems to be regulated by a circadian clock that
is independent of SCN. The circadian rhythmicity in odor
perception sensitivity accompanied by the cyclic clock gene
expression shows maximum in the early night [133].
A recent study of mouse olfactory bulb demonstrated
rhythmic VIP release by interneurons of the external plex-
iform and periglomerular layers, with the maximum in the
middle of the night. Hence, VIPergic interneurons in the
olfactory bulb seem to bewell positioned to provide circadian
coordination of cyclic processes and it is highly possible that
they play a similar role to that of VIPergic interneurons in the
SCN [131].
Studies on GABAergic transmission and its relation to
circadian rhythms in the olfactory bulb could probably
complete a picture of the postulated “olfactory clock.”
7. Cerebellum
Cerebellar cortex contains several types of inhibitory
interneurons mainly releasing GABA except for Golgi cells
that also coexpress glycine. Golgi cells provide feed backward
inhibition to excitatory interneurons, granule cells [136].
Basket and stellate cells are situated in the molecular layer
of cerebellum and cooperate with Lugaro cells, another type
of inhibitory interneurons, in the inhibition of Purkinje
cells [137, 138]. Inhibitory interneurons in the cerebellum
contain different calcium-binding proteins which can be
species-specific [139, 140].
Cerebellum contains a circadian food entrainable oscil-
lator that is responsible for the rhythm in food anticipa-
tory activity and is synchronized by the mealtime during
scheduled feeding in mammals [141]. It does not seem to be
influenced by the light/dark cycle, although the time of clock
gene expression in the cerebellum suggests a relationship
between the SCN and the cerebellar oscillator [142].
Involvement of inhibitory interneurons in cerebellar
oscillator system is unclear. Diurnal changes of GABA
turnover rate were demonstrated in hamster cerebellum in
LD 14:10 and LD 10:14. Under both light/dark conditions, the
maximumofGABA turnover ratewas achieved at night [109].
Taking into account that Purkinje cells, the principal cere-
bellar neurons, are also GABAergic, the actual contribution
of interneurons to the cyclic changes in GABA is uncertain.
However, the key role of inhibitory interneurons in all
brain structures related to the circadian clock might suggest
that also in the cerebellum the observed rhythm of GABA
turnover is evoked by rhythmic action of interneurons.
8. Striatum
GABAergic interneurons in striatum constitute at least 3-4%
of neurons [143, 144].They are medium-sized aspiny neurons
with varicose dendrites [145] and are divided into different
classes.Themain class of striatal interneurons are fast-spiking
(FS) cells expressing PV [143, 144] that are involved in the
synchronization of striatal inhibition [146]. The second class
includes interneurons containingNPY, SOM, andnitric oxide
synthase colocalizedwith CalB.They play a role in the control
of local flow of blood and in the modulation of principal cell
activity in a feedforward fashion [144, 146, 147]. The third
class of GABAergic interneurons are CalR-immunoreactive
cells [143, 148]. A distinct class of striatal interneurons are
cells which corelease GABA and dopamine [149].
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Although striatal interneurons are not numerous, there
is strong evidence that they play an important role in the
regulation of intrastriatal inhibition.
Circadian GABA fluctuations were detected in the rat
striatum under LD conditions with a peak at the end of the
day.This rhythmic pattern did not change inDDandLL (con-
stant light) conditions, suggesting that GABA rhythmicity in
this region is light-independent [150].
The influence of GABAergic transmission on the dopam-
inergic system and vice versa is particularly interesting,
because its dysfunction in the striatum seems to be critical
for Parkinson’s disease and a wide range of mood disorders.
It is also associated with drug and alcohol addictions [151].
All these disorders are characterized by disruptions of the
circadian rhythmicity [151–153].
All stages of Parkinson’s disease (PD), according to
Braak’s model [154], display disturbances in GABAergic
transmission in the striatum, especially inCa2+/GABAmech-
anism that plays the role in stabilizing neuronal activity [155].
The changes in Ca2+/GABA ratio lead to the weakening of
blood-brain barrier and the intracellular accumulation of
Ca2+ [156]. The GABAergic system protects neurons from
toxicity by the accumulation of intracellular Ca2+ via both
GABAergic receptors and glial networks [155]. Patients with
PD have changes in circadian rhythms including disruptions
of the sleep-wakefulness rhythm [157] as well as of rhythmic
changes in heart rate [158] and blood pressure [159]. PD-
associated changes in the clock gene expression were also
reported [160]. However, it is uncertain what appears first—
the circadian rhythm disruptions or PD symptoms [50].
The reward system directly involved in drug and alcohol
addictions includes the ventral striatum, especially neurons
in the core and shell of the nucleus accumbens [161, 162].
The ventral striatum seems to be mainly engaged in reward
prediction [163] and is also activated during reward antic-
ipation [164]. This striatal region is also associated with
addictive behaviors such as context-induced reinstatement of
cocaine [165] and alcohol seeking [166], while the dorsolateral
striatum is linked with reinstatement of methamphetamine
seeking [167]. During conditioned methamphetamine pair-
ing, a decrease in the level of GABA A receptor 𝛼1 subunit
was observed in the dorsal striatum, suggesting an involve-
ment of GABA A receptors in methamphetamine-associated
rewarding memory mechanism [168]. On the other hand,
methamphetamine-inducedmemory deficits were associated
with the decline in activity of GABAergic neurons caused by
the decrease in the𝛼2 subunit of GABAA receptors andGAD
protein levels in the nucleus accumbens [169, 170].
Generally, alcohol causes a decreased inhibitory and an
increased excitatory activity in neuronal networks leading to
stronger dopamine output in the ventral striatum [171]. The
decrease in GABAergic transmission level was observed in
the striatum of alcoholic brain [172]. In alcohol-dependent
rats, dopamine modulates GABA A receptors [173] and
tonic current mediated by these receptors in medium spiny
neurons of the nucleus accumbens [174]. In addition, the
prolonged ethanol consumption revealed disinhibition in the
striatum mediated by GABA A receptors, although synaptic
transmission in the nucleus accumbens was unchanged [175].
Addictions are strongly associated with disruptions of the
circadian clock. Drug and alcohol dependence are accompa-
nied by changes in the daily rhythmicity [176–178] and the
response to drugs or alcohol has different sensitivity over
the light/dark cycle [179–181]. Cocaine can induce or restrain
cyclic expression of some clock genes in the dorsal striatum
[182, 183].
The disruption in circadian rhythmicity is also correlated
with mood disorders [184, 185] which can also be induced by
mutations of clock genes [186].
Since all disorders associated with the dopaminergic
system in the striatum demonstrate a decrease in GABAergic
transmission and reveal changes in the circadian rhythmicity,
the involvement of inhibitory interneurons in striatum-
related pathology seems to be highly probable.
9. Conclusions/Concluding Remarks
Despite the fact that GABAergic interneurons form diverse
networks in different regions of the brain controlled by
the circadian clock, they generally perform similar and,
moreover, crucial role in all circuits. Inhibitory interneurons
are involved in the generation of synchronized circadian
oscillations and they are responsible for control of the excita-
tion/inhibition balance. Unfortunately, information concern-
ing diurnal or circadian changes of the particular types of
inhibitory interneurons located in different brain structures
is highly limited. Further studies of cyclic changes focused on
individual interneuron classes could significantly contribute
to the understanding of circadian clock mechanisms of their
control.
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